GB1356096A - Mineral salt preparation - Google Patents

Mineral salt preparation

Info

Publication number
GB1356096A
GB1356096A GB905373A GB905373A GB1356096A GB 1356096 A GB1356096 A GB 1356096A GB 905373 A GB905373 A GB 905373A GB 905373 A GB905373 A GB 905373A GB 1356096 A GB1356096 A GB 1356096A
Authority
GB
United Kingdom
Prior art keywords
weight
parts
preparations
salts
calcium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB905373A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of GB1356096A publication Critical patent/GB1356096A/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/06Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/42Phosphorus; Compounds thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Inorganic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

1356096 Mineral salt preparations F HOFFMANN-LA ROCHE & CO AG 23 Feb 1973 [25 Feb 1972] 9053/73 Heading A5B Mineral salt preparations for the replacement of minerals lost by bodily stress and increased transpiration as well as by the use of diuretics, contain in the form of salts, 1 to 16 parts by weight of calcium, 1 to 8 parts by weight of magnesium, 0.4 to 4 parts by weight of potassium and no sodium or less than 0.1 parts by weight of sodium, the calcium, potassium, magnesium and sodium constituting more than 2% by weight of the preparation. The salts may be the appropriate carbonates, phosphates, glycerophosphates, gluconates, ascorbates or D-pantothenates. The preparations may be administered orally in the form of powders, granulates, tablets (e.g. effervescent tablets), dragÚes, capsules, solutions, suspensions or emulsions. The preparations may also contain phosphates, vitamins, e.g. vitamin C, B 1 , B 2 , B 6 and E, nicotinic acid, nicotinamide, pantothenic acid and/or calcium D-pantothenate; sugars, e.g. glucose, lactose, fructose, saccharose, laevulose, mannitol, sorbitol or xylitol; sweetening agents; aroma additives; acid additives, e.g. citric or tartaric acid, colouring agents; solubilising agents; granulating adjuvants, preservatives; stabilisers; wetting agents; emulsifiers; salts for varying the osmotic pressure and/or buffers.
GB905373A 1972-02-25 1973-02-23 Mineral salt preparation Expired GB1356096A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH271972 1972-02-25

Publications (1)

Publication Number Publication Date
GB1356096A true GB1356096A (en) 1974-06-12

Family

ID=4240056

Family Applications (1)

Application Number Title Priority Date Filing Date
GB905373A Expired GB1356096A (en) 1972-02-25 1973-02-23 Mineral salt preparation

Country Status (14)

Country Link
JP (1) JPS4896712A (en)
AT (1) AT322743B (en)
AU (1) AU462328B2 (en)
BE (1) BE795827A (en)
CA (1) CA1023991A (en)
DE (1) DE2305979A1 (en)
FR (1) FR2173262B1 (en)
GB (1) GB1356096A (en)
IE (1) IE37291B1 (en)
IL (1) IL41347A (en)
NL (1) NL7301864A (en)
PH (1) PH9888A (en)
SE (1) SE422273B (en)
ZA (1) ZA73288B (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2157561A (en) * 1984-03-20 1985-10-30 Egyt Gyogyszervegyeszeti Gyar An injectable solution especially for treating ketosis
US5035898A (en) * 1987-11-27 1991-07-30 Schering Corporation Potassium/magnesium supplement
US11839224B2 (en) 2006-03-29 2023-12-12 Purac Biochem B.V. Partially neutralized polycarboxylic acids for acid-sanding

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI60107C (en) * 1978-02-24 1982-12-13 Suomen Laeaeketehdas Oy Salco SOM KRYDDA ELLER SOM KONSERVERINGSMEDEL FOER LIVSMEDEL ANVAENDBAR BORDSSALTPRODUKT
JPS579712A (en) * 1980-06-20 1982-01-19 Fukumi Morishige Instilling (dripping) liquid for intravenous injection
FI834309A (en) * 1983-11-24 1985-05-25 Pharmaconsult Oy SALTBLANDNING.

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2157561A (en) * 1984-03-20 1985-10-30 Egyt Gyogyszervegyeszeti Gyar An injectable solution especially for treating ketosis
US5035898A (en) * 1987-11-27 1991-07-30 Schering Corporation Potassium/magnesium supplement
US11839224B2 (en) 2006-03-29 2023-12-12 Purac Biochem B.V. Partially neutralized polycarboxylic acids for acid-sanding

Also Published As

Publication number Publication date
IE37291B1 (en) 1977-06-22
IE37291L (en) 1973-08-25
FR2173262B1 (en) 1975-10-10
JPS4896712A (en) 1973-12-10
ZA73288B (en) 1973-10-31
AT322743B (en) 1975-06-10
IL41347A (en) 1976-04-30
AU462328B2 (en) 1975-06-19
NL7301864A (en) 1973-08-28
SE422273B (en) 1982-03-01
PH9888A (en) 1976-06-08
FR2173262A1 (en) 1973-10-05
AU5122773A (en) 1974-07-18
CA1023991A (en) 1978-01-10
BE795827A (en) 1973-08-23
DE2305979A1 (en) 1973-08-30
IL41347A0 (en) 1973-03-30

Similar Documents

Publication Publication Date Title
GB1432452A (en) Sweetening agent
GB1356096A (en) Mineral salt preparation
IE882533L (en) Antiviral Compounds
GB1385086A (en) Insulin product
GR3004440T3 (en)
GB975387A (en) Multivitamin compositions
GB1431841A (en) Ophthalmic-nutritional preparations
GB1256968A (en)
GB1356097A (en) Mineral salt preparation
ES2010972T3 (en) METHOD FOR THE PREPARATION OF HIGH PURITY CRYSTALLINE LACTULOSE AND THE PRODUCT OBTAINED.
GB1344558A (en) Method for treating diseases by coenzyme a and adenosine triphosphate and composition therefor
GB1165098A (en) Improvements in the Preparation of Chlorine-Producing Bactericidal Compositions
GB933108A (en) Improvements in or relating to pharmaceutical iron preparations
JPS6479105A (en) Powder composition for beauty culture pack of occasion preparation type
GB1024408A (en) Improvements in or relating to beverage concentrates
GB1262235A (en) Compositions and beverages formed therefrom for replenishing body fluids and minerals lost through perspiration
GB1357813A (en) Effervescent composition for the treatment of heart diseases
JPH02240025A (en) Stable aqueous solution of complex vitamin
IE38383B1 (en) Doxycline parenteral composition
GB1204055A (en) Improved soft drink composition
GB1230230A (en)
GB1336609A (en) Antismoking preparation
IE41720L (en) Fungicidal and fungistatic compositions.
GB1397497A (en) Herbicidal mixture
JPS5780319A (en) Anti-tumor agent having reduced toxicity

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee